Archive:
According to Statista [1], in July 2020, the Federal Government's Corona Warning App (CWA) [2] was far ahead of all others in the ranking of the most popular apps in the Google Play Store in Germany and, according to the Robert Koch Institute (RKI), Recorded 16.8 million downloads [3]. On August 17, 2020 there were already 17.2 million, and at the beginning of November 21.9 million were registered [4]. This can certainly be seen as a success – after a long, perhaps too long, development phase. However, whether the app's intended goal of “breaking chains of infection earlier than previously possible” will be achieved and whether the software can thus be “another component of pandemic control that complements the classic contact tracking of local health authorities” remains an open question [3 ].
08.10.2020
The increase in new infections reported daily, the problem of travelers returning, the reopening of schools and kindergartens, the approaching election campaign - our group of authors needed to decide whether there should be a fourth paper after the theses from the beginning of April, the beginning of May and the end of June , no long discussions. The enormous dynamics of the current situation cannot be overlooked, especially since positive developments are now becoming visible behind the numbers, such as the quite significant drop in the hospitalization rate, the low intensive care utilization due to CoViD-19, the decline in mortality to 0.4% of infected people and - let's pick it out - initial findings of an apparently persistent cellular immunity, which seems to significantly strengthen the somewhat unreliable antibody-related defense (as is common in viral diseases).
08.10.2020
Das Institut für Epidemiologie, Sozialmedizin und Gesundheitssystemforschung der Medizinischen Hochschule Hannover (MHH) war das erste universitäre Institut seines Faches im deutschsprachigen Raum (Leitung Prof. Dr. Manfred Pflanz) und seit seiner Gründung im Jahre 1968 wegweisend für die nachfolgenden Entwicklungen an deutschsprachigen Universitäten. Unter Leitung von Prof. Dr. Friedrich Wilhelm Schwartz wurde seit Ende der 1980er Jahre die Initiierung und der (Wieder-)Aufbau der Public-Health-Forschung und -Lehre in Deutschland vorangetrieben. Aktuell hat die Leitung Prof. Dr. Ulla Walter inne. Die kommisarische Leitung hat Prof. Dr. rer. biol. hum. Marie-Luise Dierks. Sie verantwortet den Masterstudiengang Public Health und die dem Institut angeschlossene Patientenuniversität.
08.10.2020
Nach Ansicht von Dr. Dorothee Brakmann, Leiterin des Bereichs Gesundheitsökonomie, Marktzugang und Erstattung und Mitglied der Geschäftsleitung bei Janssen Deutschland, und Dr. Christoph Bug, Leiter der Medizin und Mitglied der Geschäftsführung, ist das bisher übliche und seit über 100 Jahren gebräuchliche System der Klassifikationen von Krankheiten obsolet.
08.10.2020
Cochrane has published a Special Collection of reviews, updated with three reviews, summarizing the evidence on public health measures for infection control and prevention of Covid-19. The topics of the three rapid reviews: “Quarantine” (update, published on September 14th, 2020), “Travel Restrictions” (new, published on September 16th, 2020) and “Broad-based screening” (new, published on September 15th, 2020).
08.10.2020
The study protocol of CORONA-MONITORING local*, which describes the results of a seroepidemiological study conducted by the Robert Koch Institute on the spread of SARS-CoV-2 in the population at particularly affected locations in Germany, allows for statements to be made about the proportion of the population with COVID-19 antibodies in four particularly affected German locations. The study aims to better estimate the actual extent of the epidemic, to identify risk and protective factors for infection, and thus also to identify particularly exposed groups, which – according to the authors in their study abstract – is essential for planning preventive measures.
08.10.2020
At just over three and a half years old, the medical cannabis market in Germany is still quite young - compared to other disciplines in the pharmaceutical sector. Nevertheless, new legal adjustments, an increasing number of market participants trying to get the small amount of imported goods, bad news about delivery bottlenecks, the constant battle for acceptance of cannabis as a medicinal plant and, last but not least, the global corona pandemic are causing turbulent ups and downs in the industry: This article shows INSIGHTS from current developments in the medical cannabis market.
08.10.2020
Roland Nagel, Managing Director of Gesundheitforen Leipzig GmbH, has been working with health industry data for half his life and is currently running several registers, such as the national transplant register, the RECCORD register of the German Society for Angiology and the Society for Vascular Medicine, and In addition, the evaluation center for the organized early cancer detection programs is currently preparing for the G-BA. “Monitor Healthcare Research” spoke to Roland Nagel about the current status of the big data discussion in Germany.
08.10.2020
Although the pharmaceutical market has calmed down somewhat and COVID-19 has become a part of the new normal, this article looks back at the beginning of the pandemic. In addition to the recent national changes in the prescription (Rx), over-the-counter (OTC), and medical device markets, significant regional differences are also evident. These are due to widely varying infection rates, differing age demographics, and, in particular, access to medications. Finally, the vaccine market continues to be significantly impacted by the effects of COVID-19.
28.07.2020
Dr. Paul Stoffels, global head of research at Janssen's parent company Johnson & Johnson, explains in an interview with "Monitor Healthcare Research" the background that led to the founding of the AMR Action Fund as a "new, strong alliance" against antibiotic resistance (AMR). Around 700,000 people die from AMR every year, with Stoffels adding that “by 2050, ten million people worldwide could die from uncontrollable infections every year.”